Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type. [electronic resource]
Producer: 20070925Description: 563-5 p. digitalISSN:- 1395-3907
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Exudates and Transudates
- Humans
- Injections
- Macular Degeneration -- classification
- Middle Aged
- Retinal Neovascularization -- classification
- Retrospective Studies
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- drug effects
- Vitreous Body
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.